Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.
about
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategiesCombined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.Management of patients with inflammatory bowel disease and spondyloarthritis.Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.Editorial: can we get more clinical benefit from thiopurine metabolite testing?A role for thiopurine metabolites in the synergism between thiopurines and infliximab in inflammatory bowel disease.NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease.NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients.Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.NUDT15 R139C variation increases the risk of azathioprine-induced toxicity in Chinese subjects: Case report and literature review.Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
P2860
Q30244222-90A33AC7-7FE1-488E-B196-FBAF94886810Q33758469-02BF11BE-0B98-43B1-BC57-C52107804D36Q38750966-98320FB2-F9E0-419C-8AC4-6F1AEC409706Q38768891-340AA407-3F7D-4F27-BDBA-2DAE03024774Q39334739-BF88CB05-91A3-42E5-9ADD-7A0AAF26005CQ39435409-B8DB9B65-5DEA-4704-AF29-52FF7B33E9E2Q40044141-6DBD4513-DDDA-46A6-A7C5-49418155E6DCQ40054186-CC68E7C3-3699-4A49-B89F-1C012A18C0BDQ42695266-8588631E-65D2-487A-BAE8-4827A11B7E04Q47344295-A04F7D32-02C5-4989-9EF2-CB40CACD0282Q47847637-8A930078-44FA-433A-A46B-D31FD517EEFCQ48223472-22BC0572-296F-405A-98EE-2ADF80304094Q49960165-B7E91E63-486A-4714-A10A-D5C013B2755FQ51529563-AABE6DD1-0AE0-4A6C-B91A-7DCFBB307119Q54975027-D97F4507-B891-482D-B87B-330F61F51BF0Q55259199-271FFAEC-B2BD-47EE-8BD1-0AF7C7878B8BQ55396788-FE8673DB-5AC3-4810-A9AF-1CDC82E86E72Q57817595-13D9ACEA-6E0A-47E0-A585-360AC45EE3F6
P2860
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Review article: recent advance ...... in inflammatory bowel disease.
@en
type
label
Review article: recent advance ...... in inflammatory bowel disease.
@en
prefLabel
Review article: recent advance ...... in inflammatory bowel disease.
@en
P2860
P356
P1476
Review article: recent advance ...... in inflammatory bowel disease
@en
P2093
P2860
P304
P356
10.1111/APT.13559
P407
P577
2016-02-14T00:00:00Z